PALMERI S (2004). “Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? First Messina Conference on Cancer Phamacogenomics.

“Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”

PALMERI, Sergio
2004-01-01

First Messina Conference on Cancer Phamacogenomics
PALMERI S (2004). “Weekly docetaxel (DOC) and Gemcitabine (GEM) as first line treatment for metastatic breast cancer (MBC): results of a multicenter phase II study”. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? First Messina Conference on Cancer Phamacogenomics.
Proceedings (atti dei congressi)
PALMERI S
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/6184
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact